This webinar held on January 16, 2025 was hosted by the Injectables Access Collaborative Learning and Action Network in collaboration with the Reproductive Health Supplies Coalition’s (RHSC) New and Underused Reproductive Health Technologies Caucus (NURHT).  The discussion focused on advocacy strategies for reproductive health product introduction, scale-up, and institutionalization, emphasizing what it takes to see tangible change.

Presenters shared advocacy strategies and tactics that have successfully driven change—highlighting what is needed in the often-complex space between securing an advocacy win and seeing progress toward the desired outcome. Topics included increasing access to DMPA-SC self-injection, advancing menstrual health product standards, and facilitating country-level procurement of the hormonal intrauterine device (IUD).

The Reproductive Health Supplies Visualizer (RH Viz) is a series of public-facing dashboards designed to help the RH community see integrated and aggregated supply chain inventory, order, and shipment data.

The Global Family Planning Visibility and Analytics Network (VAN) captures data from multiple sources to improve supply chain visibility. The VAN offers a platform to assess supply needs, prioritize them, and act when supply imbalances loom.

This is an open-access collection of health market literature, featuring documents and related resources needed to understand, develop, and intervene in different global health markets.

This webinar presented key findings from a two-phased research program funded by The Bill & Melinda Gates Foundation in Nigeria and Uganda. The first phase was a qualitative exploration within Focus Group discussions (total sample n=600 in 100 Focus Groups (n=6 per FG) across 8 different FG types and split across 2 urban and 2 rural settings per country) with women and their male partners (separately). The second phase was a quantitative survey with women (total sample n=1,410 women) split across 4 regions within each country.

The research explored several central topics:

• The various contraceptive journeys and experiences of women and their male partners, including satisfied and discontinued users of the injectable contraceptive (Depo), satisfied users of the DMPA-SC (Sayana Press), naïve users of modern contraceptive and those using traditional methods.
• Factors which lead to discontinuation and experiences with/perception of side effects.
• Gauged level of acceptability and preference for certain injectable attributes, in particular the impact of DMPA-SC 3 months or a potential 6 month injectable on likelihood to try. We tested 3 fully developed concepts and vary the most impactful features from phase 1 with women.
• Developed a forecast model for Depo, DMPA-SC 3-month and a potential 6-month injectable in Nigeria and Uganda.

This guide provides direction to programs that want to forecast for new and underused methods (NUMs) of family planning. It supports program managers and others involved in forecasting as they plan to introduce a contraceptive technology for the first time in a country and/or position an underused method for scale-up.

The Reproductive Health Supplies Coalition (RHSC) is a global partnership of public, private, and non-governmental organizations dedicated to ensuring that all people in low- and middle-income countries can access and use affordable, high-quality supplies to ensure their better reproductive health. The Coalition brings together diverse agencies and groups with critical roles in providing contraceptives and other reproductive health supplies. These include multilateral and bilateral organizations, private foundations, governments, civil society, and private-sector representatives.